Jentadueto XR

Jentadueto XR
4.810 ratingsReviews
Analogs:
Janumet Kombiglyze XR Kazano Synjardy Xigduo XR Invokamet Segluromet Trijardy XR Metformin Tradjenta Januvia Onglyza Nesina Jardiance Farxiga Invokana Ozempic Rybelsus Trulicity Glucophage
  • Buy Jentadueto XR online in Australia without a prescription, with 30-, 60-, 90- or 120-tablet options and delivery across the country.
  • Used alongside diet and exercise to help adults with type 2 diabetes manage their blood glucose levels.
  • Combines linagliptin and metformin in a single extended-release tablet, generally taken once daily.
  • Swallow the tablet whole with a meal at a consistent time; do not split, crush or chew it.
  • Consistent use and regular blood glucose monitoring help assess the treatment response over time.
  • Kidney function must be checked because reduced renal function increases risks associated with metformin.
  • Nausea, stomach upset and diarrhoea are common adverse effects, especially when starting treatment.
  • Could this once-daily combination simplify your diabetes routine?
In stock: 14 packs
AdultsPregnancyAllergiesBreastfeedingChildrenDriving

Dosages

Jentadueto XR 5mg+1000mg

Quantity Price per tablet You save Total price
30 A$5.27 - A$158.08
60 A$3.72 A$92.72 A$223.44
90 A$3.24 A$182.40 A$291.84
120 A$2.95 A$278.16 A$354.16

Manufacturers

Boehringer IngelheimBoehringer Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheim Pharma GmbH & Co. KGLupin Limited

Payment & Delivery

Package Example

Your order is securely packed and usually dispatched within 24 hours. Here's what a typical parcel looks like.

It is about the size of a regular letter (24x11x0.7 cm) and does not show any details of what is inside.

Front View
Front View
Side View
Side View
Back View
Back View
Delivery Times
Delivery MethodEstimated delivery
Express Free for orders over A$456.00Estimated delivery to Australia: 4-7 days
Standard Free for orders over A$304.00Estimated delivery to Australia: 14-21 days
EMSAustralia Post
Payment Methods
VisaMastercardBitcoin, USDTApple PayGoogle PayEftposAfterpayZippayKlarnaPayPal

Discount Coupons

  • Australia Day - 26 January 2026 10% AUSDAY10
  • Labour Day - 2 March 2026 6% LABOUR6
  • ANZAC Day - 25 April 2026 8% ANZAC8
  • King's Birthday - 8 June 2026 7% KING7
  • Boxing Day - 26 December 2026 12% BOXING12

Brand Names

Also known as (by country):
CountryBrand Names
Australia
Trajenta Duo

FAQ

Take the missed dose when you remember, preferably with food. If it is nearly time for the next dose, skip the missed dose and return to the usual schedule. Do not take two doses together to make up for a missed dose.

Not necessarily. Tablet colour, shape, size, markings and packaging can differ between manufacturers, even when the active ingredients, strength and dosage form match. The exact appearance of the product supplied is not guaranteed in advance.

A different appearance alone does not show that the medicine is wrong. Compare the package label for linagliptin and metformin, the 5 mg/1,000 mg strength, extended-release tablet form, manufacturer, batch number and expiry date; also compare any tablet imprint if one is present. Do not use the tablets until a discrepancy in the ingredient, strength, dosage form, imprint, seal or condition has been checked.

Store the tablets at 25°C; temperature excursions from 15°C to 30°C are permitted. If the parcel may have been outside that range, or the duration is unknown, stability cannot be confirmed. Keep the packaging, check for moisture, damaged tablets or compromised blisters, and have the product assessed before use if there is any concern.

This product is available as linagliptin 5 mg with metformin 1,000 mg in extended-release tablets. No other strength is listed for this product.

These tablets are taken by mouth, usually once daily with a meal to reduce stomach upset from metformin. Swallow extended-release tablets whole; do not split, crush or chew them, as this can alter the prolonged release. The number of tablets and exact regimen should follow the prescribed treatment plan.

This combination should be avoided during pregnancy because adequate human data for linagliptin are lacking and insulin is generally preferred for glucose control during pregnancy. It should also be avoided while breastfeeding: metformin passes into breast milk and it is not known whether linagliptin does. A clinician should arrange an appropriate alternative rather than leaving diabetes untreated.

Linagliptin and metformin are used with diet and exercise to improve blood glucose control in adults with type 2 diabetes. They are not used for type 1 diabetes or diabetic ketoacidosis. Kidney function needs assessment because metformin is cleared through the kidneys.

Description

Accessing Jentadueto XR in Australia

For Australians managing type 2 diabetes, access to a regular medicine supply can involve different practical considerations in capital cities, regional centres and remote communities. You can order Jentadueto XR for delivery to Australian addresses, while our pharmacist team is available by phone, online chat or email for questions about dosing, interactions or delivery.

Jentadueto XR in the Australian Diabetes Landscape

Jentadueto XR is a US-branded medicine rather than a familiar Australian brand. Australian clinics and pharmacists may be more familiar with locally supplied linagliptin and metformin products, and an Australian Register of Therapeutic Goods entry has not been identified for this exact US brand and formulation. That distinction matters when comparing access options: the active medicines may be established, while a particular overseas brand and package may not be part of routine Australian pharmacy supply.

For many people already managing diabetes with Metformin alone, adding a DPP-4 inhibitor such as linagliptin can provide another glucose-lowering mechanism without requiring two separate products.

Everyday Use, Best Practices and Daily Timing

Jentadueto XR is designed to be taken once daily. Its extended-release formulation controls the release of the metformin component over time. The tablet should be swallowed whole with water; splitting, crushing or chewing it can disrupt the formulation and alter medicine release. Consistency matters more than choosing a particular clock time, so it is helpful to take the dose with the same daily meal and avoid missed or doubled doses.

Morning or evening dosing

Jentadueto XR should be taken once daily with a meal. An evening meal is a convenient anchor for many people, but the most suitable time should follow the product directions and the prescriber's advice. Shift workers and people with irregular routines may find it more practical to link the dose to a reliably timed main meal rather than a fixed hour.

Taking Jentadueto XR With Meals

Taking Jentadueto XR with food helps reduce nausea, bloating and stomach upset associated with metformin. Many Australian households can link the dose to a regular family dinner, a simple meal after work or another substantial daily meal. Tea or coffee does not have a specific interaction with this medicine, although moderating caffeine may be sensible if it causes a racing heartbeat or jitteriness. Alcohol is more important: excessive drinking, especially during fasting or dehydration, can increase the risk of lactic acidosis with metformin. Avoid binge drinking and discuss alcohol use with a healthcare professional.

Safety Priorities and Activities

Linagliptin and metformin do not have a direct sedative effect, so Jentadueto XR does not automatically prevent driving or operating machinery. However, when it is used with insulin or a sulfonylurea, hypoglycaemia can impair concentration and reaction time. Kidney function should be assessed before treatment and monitored afterwards because reduced renal clearance raises the risk of metformin accumulation and, rarely, lactic acidosis. The medicine may need to be withheld under medical direction during a dehydrating illness, around major surgery or in connection with some imaging procedures that use iodinated contrast. Seek prompt medical advice rather than stopping or restarting it without guidance.

Regional Patient Perspectives

Australian patient communities, including HealthShare Australia discussions and condition-specific diabetes groups, often focus on the practical appeal of reducing the number of separate medicines that must be remembered each day. People with busy work schedules or irregular routines may find a once-daily combination easier to organise, although individual experiences differ according to tolerability, kidney function, glucose targets and other medicines. A simpler schedule does not replace regular monitoring or clinical review.

Common Challenges

Gastrointestinal discomfort is a common difficulty when starting a metformin-containing combination, although it may ease as the body adjusts. People outside major coastal cities may also need to coordinate pharmacy collection or delivery around work, travel and limited local opening hours. Cost and access are recurring concerns for anyone paying privately, so it is sensible to compare available pathways before arranging an ongoing supply.

Local Pharmacy Availability and Price Landscape

Large Australian pharmacy chains such as Chemist Warehouse, Priceline Pharmacy and TerryWhite Chemmart, along with Amcal and independent community pharmacies, are familiar access points for diabetes medicines. Availability, pricing and supply requirements can differ between pharmacies and locations, and these organisations should not be assumed to stock Jentadueto XR. Anyone seeking same-day local supply should contact a preferred pharmacy directly or ask a prescriber about linagliptin and metformin products available in Australia. Online pharmacy services can complement a local pharmacy relationship when distance, opening hours or mobility make an in-person visit inconvenient.

Online Pharmacy Trends in Australia

Australians use online pharmacy channels for practical reasons, including avoiding extra trips, coordinating several regular medicines and arranging delivery over long interstate distances. These considerations can be particularly relevant in regional, rural and remote communities where local pharmacy choices may be limited. Online access does not remove the need for appropriate medical oversight and is not suitable for every medicine or circumstance, but it can operate alongside established GP and pharmacist relationships.

PBS and Private Access

The Pharmaceutical Benefits Scheme (PBS) subsidises many medicines for eligible Australians, but listing, eligibility, authority requirements and patient contributions are product- and patient-specific. No PBS subsidy has been confirmed for this exact Jentadueto XR brand, strength and formulation. Anyone seeking subsidised access should check the current PBS listing with a pharmacist or GP. Private supply is a separate pathway, but the availability of this exact product depends on applicable Australian requirements and the supplying pharmacy.

Ingredients and How Jentadueto XR Works

Jentadueto XR contains two medicines with complementary mechanisms. Linagliptin is a DPP-4 inhibitor that slows the breakdown of incretin hormones released after eating. This helps increase glucose-dependent insulin release and reduce glucagon activity. Metformin is a biguanide that reduces glucose production by the liver and improves the body's response to insulin. The fixed-dose tablet provides both medicines in one product, with an extended-release formulation for the metformin component.

Clinical Use

This combination is intended for adults with type 2 diabetes as an adjunct to diet and exercise when treatment with both linagliptin and metformin is appropriate. It may also simplify treatment for someone already taking the two active ingredients separately. It is not used for type 1 diabetes or diabetic ketoacidosis. Treatment choice depends on glucose targets, kidney function, other health conditions, current medicines and individual tolerability.

Food, Drink and Medicine Interactions

Combining Jentadueto XR with insulin or a sulfonylurea increases the risk of hypoglycaemia, so the dose of those medicines may need review. Medicines or illnesses that impair kidney function can also increase the risks associated with metformin. This is particularly relevant during dehydration and with medicines such as non-steroidal anti-inflammatory drugs in susceptible patients. Excessive alcohol use increases the risk of lactic acidosis. Tell the prescriber and pharmacist about all prescription medicines, over-the-counter products and supplements before treatment.

Recent Evidence and Regional Insights

Fixed-dose combinations can reduce tablet burden and may help some people follow a treatment schedule more consistently than when the same medicines are taken separately. Research into DPP-4 inhibitors continues to clarify their cardiovascular safety and their place relative to other glucose-lowering options. No single combination is best for everyone. In Australia, the choice between an extended-release combination and separate tablets may reflect tolerability, clinical priorities, local availability and the practical demands of a person's daily routine.

Regional Alternatives and Choices

Other fixed-dose combinations pair metformin with different medicines. Janumet combines sitagliptin and metformin, while Kombiglyze XR combines saxagliptin with extended-release metformin. An SGLT2 inhibitor such as Jardiance uses a different mechanism and may be considered according to a person's broader treatment goals and health profile. These products are not automatically interchangeable, and the appropriate option depends on kidney function, other conditions, current treatment and tolerability.

OptionActive ingredientsDosage-form context
Jentadueto XRLinagliptin and metforminExtended-release tablet; once-daily administration
JanumetSitagliptin and metforminDosing depends on the prescribed formulation
Kombiglyze XRSaxagliptin and metforminExtended-release tablet; once-daily administration

Regulatory and Prescription Context

The Therapeutic Goods Administration (TGA) regulates medicines supplied in Australia. Jentadueto XR 5 mg/1,000 mg extended-release tablets have not been identified as an Australian Register of Therapeutic Goods medicine under this US brand and dosage form, so an Australian prescription classification cannot be confirmed for this exact product. This is separate from our ordering requirement, which does not require a prescription to be uploaded at checkout. Decisions about starting, adjusting or monitoring diabetes treatment should still involve a GP, endocrinologist or other qualified prescriber. Suspected adverse events can be reported to the TGA, and Healthdirect Australia provides general consumer health information.

Storage in Australian Household Conditions

Store Jentadueto XR at 25°C; excursions from 15°C to 30°C are permitted. In Australia, avoid locations exposed to heat spikes, such as a car glovebox, a sunny windowsill or a mailbox in direct sunlight. Bathroom humidity can also make that room unsuitable for medicine storage. Keep the tablets in their original container in a cool, dry place away from direct sunlight, and collect delivered medicine promptly during hot weather.

Delivery Across Australia

Delivery times are estimates and can vary with destination and transport conditions. Our Express option is estimated to take 4-7 days and includes tracking. Standard delivery is estimated to take 14-21 days and does not include tracking. Regional and remote customers should allow suitable lead time before their current supply runs out.

Approximate shipping times to Australian cities

CityExpressStandard
Darwin≈ 4 days≈ 15 days
Ballarat≈ 6 days≈ 19 days
Coffs Harbour≈ 4 days≈ 15 days
Geelong≈ 5 days≈ 18 days
Newcastle≈ 7 days≈ 17 days
Estimates are based on our experience with previous deliveries and are not guaranteed delivery dates.

Planning ahead is particularly important for long interstate routes and destinations outside major metropolitan delivery corridors.

In Summary

Jentadueto XR is a once-daily extended-release tablet containing linagliptin and metformin for adults with type 2 diabetes. It is taken with a meal and used alongside diet, exercise, blood glucose monitoring and appropriate kidney-function checks. Australians comparing this US-branded product with locally available options should consider its unconfirmed ARTG and PBS status, clinical suitability, delivery time and the availability of ongoing medical and pharmacist support.

Medically reviewed by
Emma Garcia
Endocrinologist and diabetologist
Updated 11 August 2026

Product specifications

Active ingredientLinagliptin and metformin
Drug classDPP-4 inhibitor and biguanide combination
Dosage formExtended-release tablets
Available strengths5 mg/1,000 mg
RouteOral
StorageStore at 25°C; excursions permitted to 15°C to 30°C.
ATC codeA10BD11

Regulatory information

Australia: medicine status
ARTG registrationJentadueto XR 5 mg/1000 mg modified-release tablets are not identified as an Australian Register of Therapeutic Goods (ARTG) medicine under this US brand and dosage form.
Prescription classificationNo Australian prescription classification can be confirmed for this exact Jentadueto XR product because an Australian ARTG entry has not been identified.
PBS subsidyNo Pharmaceutical Benefits Scheme (PBS) subsidy can be confirmed for this exact Jentadueto XR product; PBS listings must be checked by the Australian brand, strength and formulation.
Safety monitoringSuspected adverse events associated with linagliptin or metformin products can be reported to the Therapeutic Goods Administration (TGA).

More information